Duong Tran
20Patents
6h-index
33Co-inventors
65Inventor score
Filing activity: Apr 1, 2010 → May 19, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8865730B2 | Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one | Chemistry; Metallurgy | 17 | Active |
| US9708327B2 | Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one | Human Necessities | 11 | Active |
| US9567337B2 | Process methods for phosphatidylinositol 3-kinase inhibitors | Chemistry; Metallurgy | 9 | Active |
| US10047060B2 | Process methods for phosphatidylinositol 3-kinase inhibitors | Chemistry; Metallurgy | 7 | Active |
| US9469643B2 | Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one | Chemistry; Metallurgy | 7 | Active |
| US10059677B2 | Process for preparing phosphatidylinositol 3-kinase inhibitors and intermediates thereof | Chemistry; Metallurgy | 7 | Active |
| US8497396B2 | Methods and intermediates for preparing pharmaceutical agents | Emerging Cross-Sectional Technologies | 5 | Active |
| US10414737B2 | Process methods for phosphatidylinositol 3-kinase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US8853210B2 | Methods and intermediates for preparing pharmaceutical agents | Emerging Cross-Sectional Technologies | 4 | Active |
| US8987437B2 | Processes and intermediates for preparing anti-HIV Agents | Human Necessities | 3 | Active |
| US9296779B2 | Processes and intermediates for preparing anti-HIV agents | Human Necessities | 3 | Active |
| US10442805B2 | Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one | Human Necessities | 3 | Active |
| US10730879B2 | Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one | Chemistry; Metallurgy | 2 | Active |
| US9115100B2 | Methods and intermediates for preparing pharmaceutical agents | Emerging Cross-Sectional Technologies | 2 | Active |
| US11339168B2 | Crystalline forms of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as Syk inhibitors | Chemistry; Metallurgy | 1 | Active |
| US9783567B2 | Processes and intermediates for preparing anti-HIV agents | Human Necessities | 1 | Active |
| US12152037B2 | Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitor | Chemistry; Metallurgy | 1 | Active |
| US10196419B2 | Processes and intermediates for preparing anti-HIV agents | Human Necessities | 1 | Active |
| US10954199B2 | Process methods for phosphatidylinositol 3-kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9428473B2 | Methods and intermediates for preparing pharmaceutical agents | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.